These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4555926)

  • 1. Pyridoxine dependency and central nervous system excitability.
    Schlesinger K; Uphouse LL
    Adv Biochem Psychopharmacol; 1972; 4():105-40. PubMed ID: 4555926
    [No Abstract]   [Full Text] [Related]  

  • 2. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 3. Audiogenic seizures in mice: influence of agents affecting brain serotonin.
    Alexander GJ; Kopeloff LM
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):437-48. PubMed ID: 134436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 5. Audiogenic seizure susceptible rats.
    Consroe P; Picchioni A; Chin L
    Fed Proc; 1979 Sep; 38(10):2411-6. PubMed ID: 383516
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain serotonin and norepinephrine after convulsions and reserpine.
    Feighner JP; Lao L; King LJ; Ross WJ
    J Neurochem; 1972 Mar; 19(3):905-7. PubMed ID: 5030993
    [No Abstract]   [Full Text] [Related]  

  • 9. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 10. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 11. On some correlations between adrenergic and serotoninergic mechanisms of convulsive-seizure reactivity.
    Roussinov KS; Lazarova MB; Yanev SG
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):231-5. PubMed ID: 174065
    [No Abstract]   [Full Text] [Related]  

  • 12. Audiogenic seizures in mice.
    Seyfried TN
    Fed Proc; 1979 Sep; 38(10):2399-404. PubMed ID: 39007
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of brain serotonin to convulsions.
    Nelhaus G
    Neurology; 1968 Mar; 18(3):298-9. PubMed ID: 5690394
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia.
    Roberts E
    Neurosci Res Program Bull; 1972 Nov; 10(4):468-82. PubMed ID: 4663826
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

  • 17. Levels of pyridoxine and susceptibility to electroconvulsive and audiogenic seizures.
    Schlesinger K; Lieff B
    Psychopharmacologia; 1975 Apr; 42(1):27-32. PubMed ID: 1171497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between age, electroshock seizure susceptibility, and cerebral gamma-aminobutyric acid level.
    Wórum I; Pórszász J
    Acta Physiol Acad Sci Hung; 1968; 33(4):383-93. PubMed ID: 5687887
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4153869
    [No Abstract]   [Full Text] [Related]  

  • 20. p-Chlorophenylalanine-mediated decrease in susceptibility to audiogenic seizures in inbred mice.
    Alexander GJ; Kopeloff LM
    Neuropharmacology; 1977 Jun; 16(6):405-9. PubMed ID: 143621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.